Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Algesic activity of the human coronavirus OC43 derived peptide

ABSTRACT: Algesic activity of the human coronavirus OC43 derived peptide

PROVIDER: PRJNA757452 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15600773_1.fastq.gz	Fastqsanger.gz
	SRR15600773_2.fastq.gz	Fastqsanger.gz
	SRR15600774_1.fastq.gz	Fastqsanger.gz
	SRR15600774_2.fastq.gz	Fastqsanger.gz
	SRR15600775_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Algesic activity of the human coronavirus OC43 derived peptide

Project description:The human coronavirus OC43 is responsible for 15-30% of seasonal “common cold” infections with typically mild respiratory symptoms. We demonstrated that the coronavirus OC43 derived small peptide encoded by the viral p65 proteins may exhibit molecular mimicry with the pro-algesic fragment of Myelin Basic Protein (MBP). After intrasciatic injection, the p65-derived peptide induced robust pain hypersensitivity in rats lasting for up to 21 days. Transcriptomic analysis at day 21 revealed extensive spinal up-regulation of pro-nociceptive genes. Strikingly, genome-wide isoform switching due to activation of transcriptional start sites and alternative splicing events has occurred. We hypothesized that the coronavirus-derived peptides can dysregulate MBP function in the PNS/CNS and promote neuropathic chronic pain. Our findings offer paradigm-shifting mechanistic understanding of the viral origin of idiopathic neurological effects including chronic neuropathic pain, a condition currently refractory to therapeutic treatment. This new knowledge will lead to new diagnostic, prognostic, and therapeutic approaches to benefit patients with chronic pain.

2022-04-13 | GSE182706 | GEO

Human coronavirus OC43

Project description:Human coronavirus OC43 whole genome

| PRJNA1183990 | ENA

Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex [A549]

Project description:This study reports a screen to identify putative inhibitors of the eIF4F complex for potential effects on blocking coronavirus replication, using HCoV-OC43 (OC43) infection of Vero E6 cells and the lung epithelial cancer line A549 as models.

2022-12-13 | GSE198398 | GEO

Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex [Vero E6]

2022-12-13 | GSE198399 | GEO

Human coronavirus OC43